South Korea
· Delayed Price · Currency is KRW SELVAS Healthcare Statistics
Total Valuation
SELVAS Healthcare has a market cap or net worth of KRW 135.27 billion. The enterprise value is 115.27 billion.
| Market Cap | 135.27B |
| Enterprise Value | 115.27B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SELVAS Healthcare has 25.72 million shares outstanding. The number of shares has increased by 14.46% in one year.
| Shares Outstanding | 25.72M |
| Shares Change (YoY) | +14.46% |
| Shares Change (QoQ) | -8.17% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 3.94% |
| Float | 15.26M |
Valuation Ratios
The trailing PE ratio is 36.55.
| PE Ratio | 36.55 |
| Forward PE | n/a |
| PS Ratio | 4.73 |
| PB Ratio | 2.21 |
| P/FCF Ratio | 44.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 46.85, with an EV/FCF ratio of 37.58.
| EV / Earnings | 31.18 |
| EV / Sales | 4.04 |
| EV / EBITDA | 46.85 |
| EV / EBIT | 79.55 |
| EV / FCF | 37.58 |
Financial Position
The company has a current ratio of 4.06, with a Debt / Equity ratio of 14.76.
| Current Ratio | 4.06 |
| Quick Ratio | 3.14 |
| Debt / Equity | 14.76 |
| Debt / EBITDA | 3.43 |
| Debt / FCF | 2.95 |
| Interest Coverage | 6.74 |
Financial Efficiency
Return on equity (ROE) is 6.29% and return on invested capital (ROIC) is 1.51%.
| Return on Equity (ROE) | 6.29% |
| Return on Assets (ROA) | 1.42% |
| Return on Capital (ROIC) | 1.51% |
| Revenue Per Employee | 250.53M |
| Profits Per Employee | 32.43M |
| Employee Count | 114 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -48.00% |
| 50-Day Moving Average | 4,710.70 |
| 200-Day Moving Average | 5,509.08 |
| Relative Strength Index (RSI) | 60.77 |
| Average Volume (20 Days) | 2,204,951 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SELVAS Healthcare had revenue of KRW 28.56 billion and earned 3.70 billion in profits. Earnings per share was 143.92.
| Revenue | 28.56B |
| Gross Profit | 14.75B |
| Operating Income | 1.63B |
| Pretax Income | 2.39B |
| Net Income | 3.70B |
| EBITDA | 2.64B |
| EBIT | 1.63B |
| Earnings Per Share (EPS) | 143.92 |
Balance Sheet
The company has 29.06 billion in cash and 9.05 billion in debt, giving a net cash position of 20.00 billion or 777.83 per share.
| Cash & Cash Equivalents | 29.06B |
| Total Debt | 9.05B |
| Net Cash | 20.00B |
| Net Cash Per Share | 777.83 |
| Equity (Book Value) | 61.35B |
| Book Value Per Share | 2,385.49 |
| Working Capital | 35.85B |
Cash Flow
In the last 12 months, operating cash flow was 3.66 billion and capital expenditures -587.92 million, giving a free cash flow of 3.07 billion.
| Operating Cash Flow | 3.66B |
| Capital Expenditures | -587.92M |
| Free Cash Flow | 3.07B |
| FCF Per Share | 119.28 |
Margins
Gross margin is 51.66%, with operating and profit margins of 5.70% and 12.94%.
| Gross Margin | 51.66% |
| Operating Margin | 5.70% |
| Pretax Margin | 8.35% |
| Profit Margin | 12.94% |
| EBITDA Margin | 9.24% |
| EBIT Margin | 5.70% |
| FCF Margin | 10.74% |
Dividends & Yields
SELVAS Healthcare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.46% |
| Shareholder Yield | -14.46% |
| Earnings Yield | 2.74% |
| FCF Yield | 2.27% |
Stock Splits
The last stock split was on January 16, 2017. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jan 16, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.2 |